ADVB (Advanced Biomed Inc. Common Stock) Stock Analysis - SEC Filings

Advanced Biomed Inc. Common Stock (ADVB) is a publicly traded Healthcare sector company. As of May 21, 2026, ADVB trades at $4.36 with a market cap of $7.47M and a P/E ratio of -28.16. ADVB moved +0.00% today. Year to date, ADVB is -34.05%; over the trailing twelve months it is -81.51%. Its 52-week range spans $3.61 to $82.00. Rallies surfaces ADVB's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Where can I find ADVB SEC filings?

Rallies organizes ADVB SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.

ADVB Key Metrics

Key financial metrics for ADVB
MetricValue
Price$4.36
Market Cap$7.47M
P/E Ratio-28.16
EPS$-0.16
Dividend Yield0.00%
52-Week High$82.00
52-Week Low$3.61
Volume516
Avg Volume0
Revenue (TTM)$0
Net Income$-3.26M
Gross Margin0.00%

Latest ADVB News

ADVB Analyst Consensus

ADVB analyst coverage data. Average price target: $0.00.

Common questions about ADVB

Where can I find ADVB SEC filings?
Rallies organizes ADVB SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.
Does Rallies show ADVB 10-K and 10-Q filings?
Rallies organizes ADVB SEC filing research, including 10-K reports, 10-Q reports, company disclosures, and filing-driven context when available.
Is ADVB research on Rallies investment advice?
No. Rallies provides research, data, and educational context for ADVB. It does not provide personalized investment advice.
ADVB

ADVB